Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01796392 · ClinicalTrials.gov registry record · NA
Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)
A NA study, sponsored by Pulmonx Corporation.
- Completed
- Registry status
- NA
- Development phase
- 190
- Enrollment target
NCT01796392 is a NA study that has completed, run by Pulmonx Corporation. The registered enrollment target is 190 participants.
The verdict
NCT01796392, a NA study, has completed, sponsored by Pulmonx Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
Study Summary
The purpose of this research is to study an investigational medical device that is designed to produce lung volume reduction in diseased areas of the lungs in patients with severe emphysema.
Interventions
- DEVICE EBV
- OTHER Optimal Medical Management
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2013-07 |
| Est. Completion | 2023-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01796392
The ClinicalTrials.gov registry entry for NCT01796392 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pulmonx Corporation, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EBV is the first listed.
NCT01796392 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01796392 about?
NCT01796392 is a clinical study titled "Pulmonx Endobronchial Valves Used in Treatment of Emphysema (LIBERATE Study)". The purpose of this research is to study an investigational medical device that is designed to produce lung volume reduction in diseased areas of the lungs in patients with severe emphysema.
What is the current status of trial NCT01796392?
This trial is currently completed. It is a NA study. The enrollment target is 190 participants. The study started on 2013-07. Estimated completion is 2023-04.
What interventions are being tested in trial NCT01796392?
The interventions under investigation include: EBV (DEVICE), Optimal Medical Management (OTHER).
Who is sponsoring clinical trial NCT01796392?
This trial is sponsored by Pulmonx Corporation, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.